Lam Research (LRCX) PT Raised to $180 at UBS; 'Jinhua's DRAM Fab Construction Well into Foundational Stages' Citing Satellite Images
UBS raised its price target on Lam Research (NASDAQ: LRCX) to $180.00 (from $158.00) while maintaining a Buy rating, following a company update on China operations.
Analyst Stephen Chin suggests increased confidence in the company's fab construction in China, citing satellite photography from Fujian, China to support expectations of DRAM fab completion this year.
